Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. heart function
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Heart Function Articles & Analysis

65 news found

Corify Care Receives FDA Clearance for ACORYS® — Real-Time, 4-D Electroanatomical Cardiac Mapping

Corify Care Receives FDA Clearance for ACORYS® — Real-Time, 4-D Electroanatomical Cardiac Mapping

The ACORYS® System provides instant, whole-heart functional insight to support faster, safer, and more predictable ablation procedures.Designed to complement modern EP workflows, ACORYS enables real-time panoramic mapping of complex arrhythmia mechanisms, allowing clinical teams to gain immediate functional insight without pre-procedural imaging ...

ByCorify Care SL


Flottweg`s new mobile test system

Flottweg`s new mobile test system

Cutting-edge equipment Particular attention was paid to modern and functional equipment. At the heart of the truck is the Xelletor decanter X5E, which greatly expands the testing possibilities for the centrifuge manufacturer. ...

ByFlottweg SE


Creative Proteomics Introduces Advanced GST Pull-Down Service for Protein Interaction Studies

Creative Proteomics Introduces Advanced GST Pull-Down Service for Protein Interaction Studies

Protein-protein interactions lie at the heart of cellular functions, orchestrating a myriad of biological processes essential for life. ...

ByCreative Proteomics


EPA Proposes All Lead Service Lines Be Replaced within Ten Years

EPA Proposes All Lead Service Lines Be Replaced within Ten Years

In adults, lead can cause increased blood pressure, heart disease, decreased kidney function and cancer. “Lead service lines can still be found in Puerto Rico and many other islands across the Caribbean,” said Harry Pena, President of Zimmetry Environmental. ...

ByCochrane & Associates, LLC


Proposal to Replace All Lead Service Lines within a Decade Announced by EPA

Proposal to Replace All Lead Service Lines within a Decade Announced by EPA

In adults, lead can cause increased blood pressure, heart disease, decreased kidney function, and cancer. The proposed Lead and Copper Rule Improvements are an advancement in protecting children and adults from the significant health effects that can be caused by lead in drinking water. ...

ByCochrane & Associates, LLC


HTG Used for First Time in Congenital Heart Defect Surgery

HTG Used for First Time in Congenital Heart Defect Surgery

It was another first for EchoPixel when its Holographic Therapy Guidance (HTG) was used in a congenital heart surgery at Cincinnati Children’s Hospital Medical Center. ...

ByEchoPixel, Inc.


Bodyport Announces Appointment of Jim Pursley to Board of Directors

Bodyport Announces Appointment of Jim Pursley to Board of Directors

Bodyport’s focus on the patient has driven them to create an incredibly simple solution for patients with congestive heart failure. The Bodyport solution will reduce common monitoring complexities for patients while advancing how clinicians manage their patients,” Pursley said. ...

ByBodyport Inc.


1st Successful Heart Tumor Removal Without Open Heart Surgery

1st Successful Heart Tumor Removal Without Open Heart Surgery

Cloud Hospital with the first team to remove a heart tumor without invasive open heart surgery using the novel AlphaVac catheter. ...

ByEchoPixel, Inc.


Positive update from European Medicine Agency (EMA) on NTCD-M3 Phase 3 development plans

Positive update from European Medicine Agency (EMA) on NTCD-M3 Phase 3 development plans

The key points from the EMA’s feedback are that they have agreed: With the overall comparability plans relating to the development of the new easy-to-use capsule formulation of NTCD-M3, thus lifting any requirements for human trials to demonstrate such comparability That the proposed single trial Phase 3 design to be sufficient for a MAA (Marketing Authorisation Application) also ...

ByDestiny Pharma plc


Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale

Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale

This innovative solution enables people with fluid management conditions, such as heart failure and kidney disease, to noninvasively assess measures of heart function and fluid status in the same step they take to measure their weight. ...

ByBodyport Inc.


CardioWise™ Receives ISO 13485:2016 Clearance for Design, Development, and Marketing of Software as a Medical Device (SaMD) For the Medical Device Industry

CardioWise™ Receives ISO 13485:2016 Clearance for Design, Development, and Marketing of Software as a Medical Device (SaMD) For the Medical Device Industry

SQuEEZ is based on the ability in high resolution cardiac CT scans to track points on the endocardium as they move during the contraction of the heart to allow quantitative assessment of regional myocardial heart wall motion. The analysis of four dimensional SQuEEZ parameters has the potential to improve the ability to quantify accurately the regional myocardial ...

ByCardioWise Inc.


Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

Bodyport, a medtech company based in San Francisco, developed the Bodyport Cardiac Scale, a set of weighing scales that can non-invasively assess fluid status and heart function. The scales can detect these signals through the feet when a patient steps onto the device. ...

ByBodyport Inc.


Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

DSR (Direct Sodium Removal) heart failure drug development: Completed enrollment in SAHARA I[i] with first-generation DSR product (“DSR 1.0”) – extending study with second-generation DSR product (“DSR 2.0”) to support US IND[ii] filing by year end Proof-of-concept delivered in diuretic-resistant heart failure patients with ...

BySequana Medical NV


Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

– July 12, 2022 – Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today announced that the U.S. ...

ByAncora Heart, Inc


Bodyport Appoints John Lipman as Chief Executive Officer

Bodyport Appoints John Lipman as Chief Executive Officer

Lipman’s appointment comes as Bodyport prepares for commercialization of its proprietary Bodyport Cardiac Scale™, an innovative technology that remotely and noninvasively assesses heart function and fluid status in people living with fluid management conditions. ...

ByBodyport Inc.


CVRx Receives MR-Conditional Labeling Approval for its Barostim Heart Failure System

CVRx Receives MR-Conditional Labeling Approval for its Barostim Heart Failure System

Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's needs for blood and oxygen. Barostim works by stimulating baroreceptors - natural sensors in the body that tell the nervous system how to regulate heart, kidney and vascular function. These effects reduce ...

ByCVRx


Creative Enzymes Introduces a New Line of Coenzyme Products for the Supplement and Pharmaceutical Industries

Creative Enzymes Introduces a New Line of Coenzyme Products for the Supplement and Pharmaceutical Industries

In most cases, the coenzyme provides a transfer site for the functional enzyme, and it usually acts as an intermediate carrier for electrons, specific atoms, or functional groups, allowing the reaction to take place. ...

ByCreative Enzymes


BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure

BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure

“The published results from our clinical trials to date [3], [4]. [5],[6], [7] have met our high expectations in showing the therapy’s ability to address the loss of heart function in ischemic heart failure. We look forward to completing our Phase III trial and engaging with the FDA as we move closer to the prospect of benefiting ...

ByBiocardia, Inc.


Procyrion’S Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at Tct 2021 Annual Meeting

Procyrion’S Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at Tct 2021 Annual Meeting

The presentations include a spotlight on the company’s first US case treating a patient with heart failure (HF) and worsening renal function (WRF), a condition known as cardiorenal syndrome (CRS). ...

ByProcyrion, Inc.


EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans

EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans

Kosmos’ AI-driven system enables automated assessment of systolic heart function at bedside and is the only “hybrid” device in its category to provide diagnostic-quality scans while also meeting HIPAA requirements for data collection, storage, and transmission. Kosmos is rapidly emerging as a tool of choice for cardiologists and critical care ...

ByEchoNous, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT